drugset / Trial / NCT03877692
Acute Control of Chronic Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's history of preexisting hypertension, will be more effective at controlling severe hypertension during pregnancy, compared to the current standard dosing.
Timeline
- Start
- 2019-02-18
- Primary completion
- 2020-07-20
- Completion
- 2020-07-20
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Labetalol | Small molecule | 20 mg | Intravenous |
| Subject | Labetalol | Small molecule | 40 mg | Intravenous |
| Subject | Labetalol | Small molecule | 60 mg | Intravenous |
| Subject | Labetalol | Small molecule | 80 mg | Intravenous |